Skip Page Header

Home > Risk assessment report on a new psychoactive substance: methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-car- bonyl]amino}butanoate (MDMB-4en-PINACA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended).

European Monitoring Centre for Drugs and Drug Addiction. (2021) Risk assessment report on a new psychoactive substance: methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-car- bonyl]amino}butanoate (MDMB-4en-PINACA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[img]
Preview
PDF (Risk assessment: MDMB-4en-PINACA)
645kB

This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on MDMB-4en- PINACA. The report is intended for policymakers and decision-makers in the institutions of the EU. 

Table of contents

  • Statement regarding the United Kingdom
  • Contents
  • Introduction
  • Background
  • Pharmacological and toxicological properties
  • Health risks
  • Social risks
  • Extent and patterns of use, availability and potential for diffusion
  • Commercial and industrial uses, the extent of such use and its use for scientific research and developmental purposes
  • Other relevant information
  • Conclusion
Item Type
Report
Publication Type
International, Report
Drug Type
New psychoactive substance
Intervention Type
Screening / Assessment
Source
Date
12 March 2021
Pages
22 p.
Publisher
European Monitoring Centre for Drugs and Drug Addiction
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Lisbon
EndNote
Related URLs

Repository Staff Only: item control page